Turning Point Brands (TPB) director records awards, tax shares and gift
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Turning Point Brands director Lawrence Wexler reported several equity-related transactions in company stock. On March 2, 2026, he acquired 8,369 and 927 shares of common stock at $108.51 per share, reflecting settlement of performance restricted units granted in February 2021 and March 2022 after the compensation committee determined the performance criteria were met.
Also on March 2, 3,393 shares were disposed of at a weighted-average price of $100.14 to cover tax obligations by delivering shares rather than cash. Earlier, on December 26, 2025, Wexler made a bona fide gift of 2,800 shares to a donor advised fund. Following these transactions, he reported direct ownership of 286,394 shares of common stock and 2,205 restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary
2,800 shares gifted
Mixed
9 txns
Insider
Wexler Lawrence
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 8,369 | $108.51 | $908K |
| Grant/Award | Common Stock | 927 | $108.51 | $101K |
| Tax Withholding | Common Stock | 3,393 | $100.14 | $340K |
| Gift | Common Stock | 2,800 | $0.00 | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
| holding | Options | -- | -- | -- |
Holdings After Transaction:
Common Stock — 288,860 shares (Direct);
Options — 15,900 shares (Direct)
Footnotes (1)
- Reports the donation of 2,800 shares of common stock to a donor advised fund. The total reported in Column 5 includes 2,205 restricted stock units and 278,286 shares of common stock. Reports common stock issued upon settlement of performance restricted units granted to the reporting person in February 2021. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 2,205 restricted stock units and 286,655 shares of common stock. Reports common stock issued upon settlement of performance restricted units granted to the reporting person in March 2022. The compensation committee of the Board of Directors determined that the performance criteria were met on March 2, 2026. The total reported in Column 5 includes 2,205 restricted stock units and 287,582 shares of common stock. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.87 - $101.97. The total reported in Column 5 includes 2,205 restricted stock units and 284,189 shares of common stock. Granted pursuant to the issuer's 2015 Equity Incentive Plan. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2018, 33% of the underlying shares on January 1, 2019 and 33% of the underlying shares on January 1, 2020. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2021, 33% of the underlying shares on January 1, 2022 and 33% of the underlying shares on January 1, 2023. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2022, 33% of the underlying shares on January 1, 2023 and 33% of the underlying shares on January 1, 2024. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2020, 33% of the underlying shares on January 1, 2021 and 33% of the underlying shares on January 1, 2022. The options vest and become exercisable as to 34% of the underlying shares on January 1, 2019, 33% of the underlying shares on January 1, 2020 and 33% of the underlying shares on January 1, 2021.
